U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C13H8F3N2O2.Na
Molecular Weight 304.1998
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of TRIFLOCIN SODIUM

SMILES

[Na+].[O-]C(=O)C1=CN=CC=C1NC2=CC(=CC=C2)C(F)(F)F

InChI

InChIKey=YOUXBFJNMBEOPV-UHFFFAOYSA-M
InChI=1S/C13H9F3N2O2.Na/c14-13(15,16)8-2-1-3-9(6-8)18-11-4-5-17-7-10(11)12(19)20;/h1-7H,(H,17,18)(H,19,20);/q;+1/p-1

HIDE SMILES / InChI

Molecular Formula C13H8F3N2O2
Molecular Weight 281.21
Charge -1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Molecular Formula Na
Molecular Weight 22.98976928
Charge 1
Count
Stereochemistry ACHIRAL
Additional Stereochemistry No
Defined Stereocenters 0 / 0
E/Z Centers 0
Optical Activity NONE

Triflocin is a nicotinic acid derivative. Triflocin is a diuretic agent. It is structurally dissimilar from ethacrynic acid and furosemide although their natriuretic potency and site of action in the kidney appear similar. Triflocin inhibits sodium-stimulated, ouabain-insensitive ATPase. In vivo, a natriuretic effect of Triflocin has been reported in both the proximal convoluted tubule and the thick ascending limb of Henle's loop. Upon acute isohydric hypercapnia, Triflocin depolarizes the basolateral membrane potential. Triflocin inhibits the basolateral electrogenic Na-(HCO3)n > 1 cotransport in proximal tubules.

Approval Year

PubMed

PubMed

TitleDatePubMed
Effect of locally applied drugs on the pH of luminal fluid in the endolymphatic sac of guinea pig.
2000-11
Triflocin, a novel inhibitor for the Na-HCO3 symport in the proximal tubule.
1994-06
Characterization and localization of ouabain-insensitive Na-dependent ATPase activities along the rat nephron.
1991-05-07
Ouabain insensitive Na+-stimulated ATPase activity associated to basal-lateral plasma membranes of rat kidney cells.
1983
Partial characterization of the ouabain-insensitive, Na+-stimulated ATPase activity of kidney basal-lateral plasma membranes.
1982-10-22
Interference with feedback control of glomerular filtration rate by furosemide, triflocin, and cyanide.
1974-06
Micropuncture study of the effect of triflocin on tubular reabsorption in rats.
1973-02
The effect of triflocin, a new diuretic drug, on the renal concentrating mechanism.
1972-10-01
Effects of triflocin on renal tubular reabsorption and blood flow distribution.
1972-07
Ouabain-uninhibited Na+ Transport in human erythrocytes: the effects of triflocin.
1972-02-11
Renal mechanisms of the natriuretic and antiphosphaturic effects of triflocin--a new diuretic.
1970-08
The effect of a new diuretic, triflocin (4-(alpha,alpha,alpha-trifluoro-m-toluidino)-nicotinic acid) on blood glucose in the rat and dog.
1969-09
Patents

Patents

Substance Class Chemical
Created
by admin
on Mon Mar 31 17:54:24 GMT 2025
Edited
by admin
on Mon Mar 31 17:54:24 GMT 2025
Record UNII
C391E67F4Z
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
3-PYRIDINECARBOXYLIC ACID, 4-((3-(TRIFLUOROMETHYL)PHENYL)AMINO)-, SODIUM SALT (1:1)
Preferred Name English
TRIFLOCIN SODIUM
Common Name English
Code System Code Type Description
FDA UNII
C391E67F4Z
Created by admin on Mon Mar 31 17:54:24 GMT 2025 , Edited by admin on Mon Mar 31 17:54:24 GMT 2025
PRIMARY
CAS
13856-39-8
Created by admin on Mon Mar 31 17:54:24 GMT 2025 , Edited by admin on Mon Mar 31 17:54:24 GMT 2025
PRIMARY
EPA CompTox
DTXSID80160712
Created by admin on Mon Mar 31 17:54:24 GMT 2025 , Edited by admin on Mon Mar 31 17:54:24 GMT 2025
PRIMARY
PUBCHEM
71586970
Created by admin on Mon Mar 31 17:54:24 GMT 2025 , Edited by admin on Mon Mar 31 17:54:24 GMT 2025
PRIMARY
Related Record Type Details
PARENT -> SALT/SOLVATE
Related Record Type Details
ACTIVE MOIETY